{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T01:22:12Z","timestamp":1700184132022},"reference-count":17,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.ejso.2003.09.002","type":"journal-article","created":{"date-parts":[[2003,10,28]],"date-time":"2003-10-28T16:17:21Z","timestamp":1067357841000},"page":"916-921","source":"Crossref","is-referenced-by-count":14,"title":["Prognostic factors for survival after isolated limb perfusion for malignant melanoma"],"prefix":"10.1016","volume":"29","author":[{"given":"E.M","family":"Noorda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.C","family":"Vrouenraets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.E","family":"Nieweg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.N","family":"van Geel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.M","family":"Eggermont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.B.R","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2003.09.002_BIB1","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/bjs.1800831004","article-title":"Thirty-five years of isolated limb perfusion for melanoma: indications and results","volume":"83","author":"Vrouenraets","year":"1996","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2003.09.002_BIB2","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1200\/JCO.1996.14.10.2653","article-title":"Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial","volume":"14","author":"Eggermont","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2003.09.002_BIB3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00008390-199910000-00009","article-title":"Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study","volume":"9","author":"Li\u00e9nard","year":"1999","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejso.2003.09.002_BIB4","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American joint committee on cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2003.09.002_BIB5","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0039-6109(05)70517-X","article-title":"Isolated hyperthermia chemotherapy perfusion for limb melanoma","volume":"76","author":"Krementz","year":"1996","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.ejso.2003.09.002_BIB6","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1002\/1097-0142(19890615)63:12<2551::AID-CNCR2820631233>3.0.CO;2-7","article-title":"Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion","volume":"63","author":"Di Filippo","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2003.09.002_BIB7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10434-001-0771-4","article-title":"Factors affecting survival after complete response to isolated limb perfusion in patients with in-transit melanoma","volume":"8","author":"Zogakis","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2003.09.002_BIB8","first-page":"564","article-title":"Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion","volume":"178","author":"Klaase","year":"1994","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ejso.2003.09.002_BIB9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0959-8049(93)90377-R","article-title":"Results of a double perfusion schedule with melphalan in patients with melanoma of the lower limb","volume":"29A","author":"Kroon","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2003.09.002_BIB10","first-page":"305","article-title":"Results of a double perfusion schedule using high-dose hyperthermia and melphalan sequentially for recurrent melanoma of the limbs: a pilot study","author":"Kroon","year":"1992","journal-title":"Reg Cancer Treatment"},{"key":"10.1016\/j.ejso.2003.09.002_BIB11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","article-title":"Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions","volume":"18","author":"Wieberdink","year":"1982","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.ejso.2003.09.002_BIB12","unstructured":"WHO Handbook for Reporting Results of Cancer Treatment. Geneva: WHO; 1979."},{"key":"10.1016\/j.ejso.2003.09.002_BIB13","series-title":"Applied Multiple Regression\/Correlation Analysis for the Behavioural Sciences","author":"Cohen","year":"1975"},{"key":"10.1016\/j.ejso.2003.09.002_BIB14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(95)90463-8","article-title":"Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European society for hyperthermic oncology","volume":"345","author":"Overgaard","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2003.09.002_BIB15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0748-7983(97)93726-4","article-title":"Carbon dioxide laser for cutaneous melanoma metastases: indications and limitations","volume":"23","author":"Strobbe","year":"1997","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2003.09.002_BIB16","first-page":"39","article-title":"Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan","volume":"115","author":"Klaase","year":"1994","journal-title":"Surgery"},{"issue":"Supplement","key":"10.1016\/j.ejso.2003.09.002_BIB17","first-page":"S8","article-title":"A phase III trial of isolated limb perfusion for extremity melanoma comparing melphalan alone versus melphalan plus tumor necrosis factor (TNF) plus interferon gamma","author":"Fraker","year":"2002","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798303002014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798303002014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T09:27:50Z","timestamp":1550482070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798303002014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0748798303002014"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2003.09.002","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}